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At present, due to environmental and economic concerns, it is urgent to evolve efficient, clean and secure systems
for the production of advanced biofuels from sustainable cheap sources. Biobutanol has proved better characteristics
than the more widely used bioethanol, however the main disadvantage of biobutanol is that it is produced in low
yield and titer by ABE (acetone-butanol-ethanol) fermentation, this process being not competitive from the economic
point of view. In this review we summarize the natural metabolic pathways for biobutanol production by Clostridia and
yeasts, together with the metabolic engineering efforts performed up to date with the aim of either enhancing the
yield of the natural producer Clostridia or transferring the butanol production ability to other hosts with better
attributes for industrial use and facilities for genetic manipulation. Molasses and starch-based feedstocks are main
sources for biobutanol production at industrial scale hitherto. We also review herewith (and for the first time up to
our knowledge) the research performed for the use of whey, the subproduct of cheese making, as another sustainable
source for biobutanol production. This represents a promising alternative that still needs further research. The use of
an abundant waste material like cheese whey, that would otherwise be considered an environmental pollutant, for
biobutanol production, makes economy of the process more profitable.
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Biobutanol as energy source
The limited availability and rising price of fossil fuels,
together with the growing concern on the greenhouse
effect and the climate change, urge to evolve efficient,
clean and secure systems for the production of advanced
biofuels from sustainable cheap sources.
Nowadays bioethanol is the most widely used, blended
with gasoline at various percentages, but biobutanol has
proved better characteristics. The term biobutanol includes
four butanol isomers: n-, sec-, tert- and, mainly, isobutanol
with a low melting temperature and the highest octane
number (a measure of anti-knock properties). Isobutanol
and n-butanol are the most largely manufactured.
Biobutanol energy value is similar to gasoline and
30% higher than ethanol; it can be used mixed with
gasoline up to any level and even pure, while ethanol
only can be used mixed with gasoline up to a limited
level; since it is not hygroscopic, it can be blended with
gasoline at the refinery, while ethanol and gasoline must* Correspondence: migs@udc.es
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unless otherwise stated.be blended just before use; also it can be blended up to
40% with diesel or biodiesel and can be upgraded to
aviation jet biofuel; biobutanol can be used without
modification of existing automotive engines both in pure
or blended forms; it is non-corrosive and then also the
existing infrastructure of pipelines, tanks, pumps, etc. can
be used; and finally its vapour pressure is lower than the
one of ethanol, being therefore of safer handling [1-4].
Historically, the ABE (acetone–butanol–ethanol)
fermentation process by solventogenic Clostridium
species was industrially employed from the early 20th
century till the Second World War when it was replaced
by the production from petroleum. The onset of the
renaissance of fermentative production is dated about
the 1980s, but up to the 21st century butanol was
used just as a bulk chemical; in 2005 the successful use of
butanol in an unmodified car completely replacing gasoline
was reported, and thereafter interest in biobutanol
production for fuel use has been increasingly emphasized
[5]. As an example, the web page http://www.biofuelstp.
eu/butanol.html (date of reference 08/01/2015) mentions
that in December 2013, the company Gevo announced
successful trials by the US Army of a 50/50 blend of a
Gevo’s fuel in a helicopter.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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production through ABE fermentation is not cost-effective
compared with other biofuels such as ethanol, since yield
and titer of butanol are lower; therefore the improvement
of substrates, microbial strains and processes for its cost-
competitive production is a matter of priority research [4].
An approach to compare the range of yield and
economics of biobutanol and bioethanol productions
was made by Pfromm et al. in 2010 [6]. The authors
compared the fermentative production of n-butanol vs.
ethanol from corn or switchgrass in terms of the lower
heating value (LHV) of the liquid fuel products per unit
mass of the feedstock, and they found that the energy
yield of butanol using ABE technology was about half of
ethanol with both substrates. Reasons include that the
ABE fermentation converts a substantial amount of carbon
to acetone which cannot be used as a fuel, that ABE
fermentation produces relatively more CO2 than yeast
alcoholic fermentation, and that more starch remains
unfermented. A given fermenter volume produced
about one-quarter of the LHV as n-butanol per unit
time compared to ethanol. They also report, in terms
of carbon mass balance, industrially confirmed yields
for fuel ethanol production by yeast equivalent to
about 0.30 kg pure ethanol per kg corn and, for ABE
fermentation by C. acetobutylicum, equivalent to
about 0.11 kg n-butanol per kg of corn (3 kg of starch
converted to 1 kg of mixed solvents with a weight ratio of
n-butanol/acetone/ethanol of 6/3/1). Ethanol fermentation
reaches about 15% (equivalent to ~7% of ethanol saturation
in water) while ABE fermentation reaches about 2%
n-butanol (equivalent to ~25% of n-butanol saturation
in water). To equal the yeast based bio-ethanol process
these authors estimate that n-butanol yield should
increase from about 0.11 to 0.19 kg n-butanol per kg corn.
Even though during the last years diverse efforts to
improve biobutanol fermentative production have
been performed, as here reviewed, yield is still a
bottle-neck [4] as long as feedstock costs can be the
highest fraction of the overall production cost of bio-based
liquid fuels; thus on a conventional plant, corn starch
is reported to account for up to 79% of the overall
solvent production cost [7].
Molasses and starch are main sources for butanol manu-
facture hitherto. However, molasses show a geographical
limitation and starchy raw materials, such as corn and
wheat, are food or feed supplies and then are not available
for biofuels large-scale manufacture. Moreover, lignocellu-
losic residues that are plentiful and very cheap have been
widely investigated but their recalcitrance to degradation,
and the generation of inhibitors of the process, challenge
production of butanol. So that alternative sustainable
sources for biobutanol production are still needed [4].
A similar situation could be described for bioethanolproduction. Other waste materials, like cheese whey,
that would otherwise be considered environmental
pollutants can be converted into energy sources, thus
making the pathway to a biofuel-based economy more
feasible [8]. Cheese whey is already a substrate for
bioethanol production at industrial scale [9] but its use for
biobutanol production has been less investigated and
needs further research, as here reviewed.
Review
The metabolic pathways in the production of biobutanol
Natural producers of biobutanol
Clostridium species are natural producers of n-butanol
through a biosynthetic pathway that depends on acetyl-CoA
sources, the CoA-dependent pathway. Well-known species
from Clostridia producing biobutanol are C. acetobutylicum,
C. saccharoperbutylacetonicum, C. beijerinckii, C.
saccharoacetobutylicum, C. aurantibutyricum, C. cadaveris,
C. sporogenes, C. pasteurianum, and C. tetanomorphum.
Among them, the first four species produced the highest
yields [10]. In Clostridia acetyl-CoA is produced from
diverse carbon sources, also including lactose, the
sugar present in whey [11,12]. The fermentation of
these sugars usually proceeds in batch mode in two
phases. The first (acidogenesis) produces acetic and
butyric acids and the second (solventogenesis) acetone,
butanol and ethanol (thus named ABE fermentation). In
the CoA-dependent pathway two acetyl-CoA molecules
are used to generate a C4 molecule, followed by re-
duction into n-butanol. The enzymes, coenzymes and
stereo-specificity of each reaction to produce n-butanol
are shown in Figure 1. The first problem to make this
process economically attractive for the production of
biobutanol is that it is necessary to find a way to easily
shift the metabolism of natural producers from the
acidogenic phase towards solventogenesis. Besides, it
is necessary to avoid the toxicity of the solvent products,
which are mostly attributed to the action of butanol on the
microbial cell membranes due to its chaotropic effect [13].
Butanol concentrations over 2% seriously compromise
bacterial survival [14].
Another natural metabolic pathway for the production
of biobutanol is by deviation of metabolic intermediates
from the biosynthesis of aliphatic amino acids in yeast
[15,16]. In some yeast species producing fusel alco-
hols as fermentation by-products, the Ehrlich pathway
decarboxylates keto acids and produces aldehydes,
which are finally reduced to alcohols. Since keto acids
are the precursors of amino-acids, n-propanol is obtained
from isoleucine, isobutanol from valine and n-butanol from
norvaline pathways (Figure 1). Isobutanol is the preferred
for industrial use because it has a better octane number
than n-butanol. The industrial application is hampered by
the very low intrinsic production in yeast. This route is
Figure 1 Scheme of the biobutanol synthesis metabolic pathways in Clostridia and yeast.
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mediates, which are necessary for amino acid biosynthesis
and therefore it is not naturally favoured.
Engineered pathways in bacteria
Two main strategies for improving biobutanol production
in bacteria can be considered. The first one is based on
regulatory and metabolic engineering of bacteria from the
Clostridia, and all attempts in this field aim to avoid
undesired products and to increase the yield of alcohols
obtained as well as the tolerance to butanol. The second
one is the engineering of non-producer bacteria with
heterologous pathways of biobutanol biosynthesis from
natural producers or with artificially generated pathways
combining enzymes from different genera. Table 1 sum-
marizes the techniques employed, yield and productivity
reached for butanol and ABE.
Towards a better solventogenic Clostridium producer
Several attempts to improve C. acetobutylicum by muta-
genesis were successful. A better tolerance to butanol, a
higher yield and improved sugar source utilization wereachieved by these approaches (reviewed in [5]). Several
species of Clostridium have been also engineered in order
to make possible the use of alternative carbon sources
such as: liquefied corn flour [18], glycerol [19] and a
mixture of hydrogen and carbon monoxide [20].
A direct way to improve fuel alcohols production is to
avoid acetone formation in the ABE process [29,30].
This strategy has been pursued by inactivation of the
adc gene, encoding the acetoacetate decarboxylase and
necessary for acetone synthesis [21]. Another approach
consists in obtaining isopropanol from acetone by
metabolic engineering. The mixture of isopropanol,
butanol, and ethanol (IBE) produced by engineered C.
acetobutylicum is also useful as biofuel. The gene
encoding the required dehydrogenase from C. beijerinckii
and other genes have been transferred to C. acetobutylicum
[22,23]. A recently reported IBE strain produces 99%
of fuel alcohols with negligible amount of acetone
[23]. Usually metabolic engineering is a pyramidal
task in which the starting strain has been already
obtained by improving metabolic fluxes and yield by
a previous approach [23].
Table 1 Metabolic engineering approaches to improve biobutanol production by bacteria
Bacteria and engineering technique Fuel concentration Productivity Reference
g/L g/L h
Clostridium acetobutylicum not engineered B: 8.3 nr [17]
Clostridium beijerinckii engineered to use liquefied corn flour + product recovery ABE: 81.3 nr [18]
Hyper butanol producing strain of Clostridium pasteurianum isolated by chemical
mutagenesis and optimized to produce butanol from glycerol in bach culture
B: 17.8 B: 0.43 [19]
Idem to previous in continuous culture nr ABE: 8.30 [19]
B: 7.80
Clostridium ljungdahlii engineered to use a mixture of hydrogen and carbon monoxide butanol produced, but only detectable
during middle growth phase, then it
is metabolized to butyrate
[20]
Clostridium acetobutylicum engineered by inactivation of the adc gene, encoding the
acetoacetate decarboxylase and necessary for acetone synthesis.
B: 14.8 nr [21]
BE: 18.1
Clostridium acetobutylicum engineered with a synthetic operon for obtaining isopropanol
from acetone
IBE: 35.6 IBE 0.83 [22]
Clostridium acetobutylicum engineered for obtaining isopropanol from acetone IBE: 27.9 nr [23]
Clostridium ljungdahlii transformed with a plasmid, carrying the C. acetobutylicum
butanol synthesis pathway genes
B: 0.15* [24]
Escherichia coli engineered to produce isopropanol and butanol with genes from
C. acetobutylicum and others
I: 4.9 I: 0.4 B: nr [25]
B: 0.5
Escherichia coli engineered to produce butanol with genes from C. acetobutylicum B: 0.20-0.58 nr [26]
Pseudomonas putida engineered to produce butanol with genes from C. acetobutylicum B: 0.12 nr [26]
Bacillus subtilis engineered to produce butanol with genes from C. acetobutylicum B: 0.02 nr [26]
Lactobacillus brevis engineered to produce butanol with genes from C. acetobutylicum B: 0.30 nr [17]
Synthetic butanol pathway expressed in Escherichia coli B: 4.65 nr [27]
Modified Escherichia coli by the 2-keto-acid pathway B: 20 B: 0.18 [25]
Modified Corynebacterium glutamicum by the 2-keto-acid pathway B: 4.9 nr [28]
*in the middle of the exponential growth phase but consumed by the organism (only 0–15 mg/L left at the end of growth).
A: Acetone; B: 1 or 2-butanol; E: Ethanol; I: Isopropanol; nr: not reported.
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In the production of butanol by solventogenic Clostridia
starchy substrates or molasses are consumed as carbon
sources. To avoid competence with nutritional feedstock,
an alternative is the utilization of gaseous substrates
and acetogenic Clostridia [24]. Following this strategy
C. ljungdahlii was transformed with a plasmid, carry-
ing the genes thlA, hbd, crt, bcd, adhE, and bdhA of
the C. acetobutylicum butanol synthesis pathway;
these genes encode the thiolase, 3-hydroxybutyryl-CoA
dehydrogenase, crotonase, butyryl-CoA dehydrogenase,
butanol/butyraldehyde dehydrogenase, and butanol
dehydrogenase, respectively [20].
The introduction of the Clostridium butanol pathway
into other bacteria that grow faster, are more resistant to
butanol or metabolize alternative substrates might solve
some of the limitations observed in Clostridium. Escherichia
coli has a higher growth rate than Clostridia and has been
engineered to produce butanol [25,31]. Pseudomonas putida
that overcomes butanol toxicity by specific efflux pumps or
Bacillus subtilis that becomes more resistant by changingits cell-wall composition are also selected hosts [26].
Lactobacillus brevis that has a high tolerance to butanol,
and is able to digest C5 and C6 substrates, has also been
used [17].
The production of butanol is principally limited by the
intrinsic kinetic characteristics and cofactor specificity of
the enzymes of the natural Clostridium pathway, with
independence of the selected host organism. This limitation
can be overcome by using a synthetic pathway. This has
been done by combining convenient enzymes from four
different organisms into a synthetic butanol pathway
expressed in E. coli [27]. The use of a 2-keto-acid decarb-
oxylase of low substrate specificity together with an alcohol
dehydrogenase into a modified E. coli strain produces high
yields of isobutanol by the 2-keto-acid pathway [25,31,32].
The 2-keto-acid pathway of Corynebacterium glutamicum
has also been engineered, taking advantage of the high
amino-acid production characteristic of this bacteria [28].
In summary, reviewing the main strategies used for
biobutanol production in bacteria (Table 1) several
conclusions arose. First, using natural producers, the
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fermentation conditions in combination with product
recovery techniques that may avoid toxicity [18]; or those
that increase fuel concentration by avoiding the production
of acetone [21] or deviate this metabolite to the production
of isopropanol [22]. These approaches allow a two to ten
folds increase of achieved fuel concentration in comparison
to the original, not engineered, strains of Clostridium
acetobutylicum. The introduction of the metabolic
pathway for ABE fermentation in other bacteria, considered
advantageous because they do not require anaerobic
fermentations, grow faster or are more tolerant to butanol,
has been less successful since the reached concentration of
fuel are far below those obtained for the natural producers
[17,25,26]. A promising area is the engineering of
non-natural producer bacteria with the 2-keto-acid
pathway, which has increased more than two folds
the fuel concentration in comparison to natural strains of
Clostridium acetobutylicum [25].
Engineered pathways in yeasts
Although in hitherto published papers engineered
Clostridia or E. coli show higher yields of biobutanol
production than yeasts [33], it has been reported that
industry opts for engineered Saccharomyces cerevisae
for isobutanol high-scale production systems [2]. One
reason may be the good previous operational experience
about bioethanol production by this yeast together with
the possibility to adapt the same infrastructure. In fact,
the companies producing biobutanol by recombinant
yeasts are or were bioethanol producers. A visit to the web
page http://www.biobutanol.com/ or to those of the
companies Gevo, Butamax or Butalco (date of reference
2014-10-06) support these statements. Moreover, there are
several drawbacks with the use of bacteria for biobutanol
production in industry such as requirement for strictly
anaerobic conditions in the Clostridium species, a
complex separation process from the fermentation media,
narrow and neutral pH growth rate and susceptibility to
phage infections when grown on a large scale [4,34].
These drawbacks associated to bacterial fermentations
support the use of yeast.
S. cerevisae has the enzymes to synthesize isobutanol
by the two-compartment Erhlich pathway, in which
ketoisovalerate (an intermediary product of mitochondrial
valine biosynthesis) is catabolized into isobutanol in the
cytosol, although levels produced naturally are low
(Figure 1). The strategies of yeast metabolic engineering
employed by different research groups, from academy or
industry, to improve biobutanol production (as reviewed
by [2,35]) are varied and can be summarized as follows:
Overexpression of ILV2, ILV5 and ILV3, the own genes of
the valine biosynthesis pathway encoding acetolactate
synthase, ketoacid reductoisomerase and dihydroxyaciddehydratase, respectively; expression of all enzymes
involved in isobutanol synthesis into mitochondria using a
mitochondrial transport signal; external addition of ketoi-
sovalerate to be converted by heterologous decarboxylases
and alcohol dehydrogenases, combined with disruption of
the PDC1 gene, encoding pyruvate decarboxilase; expres-
sion of the valine biosynthetic pathway in the cytosol by
removing the mitochondrial targeting signals of the genes
ILV2, ILV5 and ILV3 or introducing heterologous genes,
but keeping the mitochondrial pathway intact; replace-
ment of the mitochondrial pathway by a cytosolic pathway
to avoid competition, which was got by over-expression of
cytosolic forms encoded by ILV2, ILV5, ILV3, ARO10 or
other ketoacid decarboxylase, and ADH2 or other alcohol
dehydrogenase, together with deletion of mitochondrial
ILV2 and the three pyruvate decarboxilase encoding genes
(PDC1, PDC5, PDC6); increase of cytosolic acetyl-CoA
supply (by expression of the E. coli pyruvate dehydrogenase
complex) together with reduction of pyruvate decarboxilase
endogenous activity and expression of the butanol synthetic
pathway from Clostridia. Moreover, additional genetic
manipulations were performed to overcome the lack of
growth on glucose as single carbon source of the pyruvate
decarboxilase mutant (pdc-) strains, to reduce other
by-products formation besides ethanol, to increase
dihydroxyacid dehydratase (encoded by ILV3 or heterologous
genes) activity, or to correct cofactor imbalance. Combin-
ing several of these strategies more than 80% of the
maximum isobutanol theoretical yield was reached.
Also, Brat et al. [36] adapted the codon usage of the
cytosolic expressed genes of valine biosynthesis to those
of the highly expressed genes of glycolysis.
More recently, during the last 2 years (2013–2014)
new yeast metabolic engineering approaches have been
published that are following summarized. Also, in Table 2
a selection of engineered S. cerevisiae strains, only those
producing isobutanol and recently published, is summa-
rized, showing reported yield and/or titer reached.
Branduardi et al. [38] proposed an alternative way
based in exploiting the catabolic pathway of amino acids
resulting from hydrolysis of proteins, where proteins
come from dead microbial biomasses at the end of
fermentation. The authors demonstrated how glycine
could be the substrate for the synthesis of butanol and iso-
butanol in S. cerevisiae following the pathway glyoxylate,
β-ethylmalate, α-ketovalerate and α-ketoisovalerate. No
heterologous activities were used.
Krivoruchko et al. [34] reconstructed the 1-butanol
biosynthetic pathway in S. cerevisae. This was done by
increasing flux towards cytosolic acetyl-CoA by means of
the transformation with a plasmid expressing the genes
ADH2 (alcohol dehydrogenase), ALD6 (acetaldehyde
dehydrogenase), ACS1/ACS2 (acetyl-CoA synthetase), and
ERG10 (acetyl-CoA acetyltransferase). Also using null
Table 2 Metabolic engineering approaches to improve isobutanol production by the yeast S. cerevisiae
Yeast S. cerevisiae engineering technique and carbon source Isobutanol concentration
and/or yield
Observations Reference
Overexpression of biosynthetic genes ILV2, ILV3, and ILV5 in valine metabolism.
Aerobic batch cultures in 40 g/L glucose.
4.12 mg/g glucose First report of isobutanol
production by yeast. (2011)
[37]
Expression of a cytosolic pathway consisting of ILV2, ILV5, ILV3, ARO10, and
ADH2, and deletion of the first gene of the mitochondrial pathway. Batch
cultures in 4% glucose.
630 mg/L, The highest titer reported
up to the date (2012)
[36]
15 mg/g glucose
Characterization of an alternative metabolic pathway for butanol and
isobutanol production, using glycine as a substrate via glyoxylate and
α -ketoacids intermediates.
58 mg/L Isobutanol from glycine
(2013)
[38]
Elimination of competing pathways in strains lacking genes encoding
members of the pyruvate dehydrogenase complex (LPD1) and resolving
the cofactor imbalance by overexpression of enzymes responsible for
transhydrogenase-like shunts transforming NADH into NADPH. 24 hours
batch fermentation in 100 g/L glucose.




Compartmentalization of the Ehrlich pathway into mitochondria. 635 mg/L Increased isobutanol
production by 260% (2013)
[40]
Batch semi-aerobic cultures in 20% glucose.
Fermentation of D-xylose directly to isobutanol: Overexpression of an
optimized, cytosolically localized valine biosynthesis pathway together
with xylose isomerase XylA from Clostridium phytofermentans, transaldolase
Tal1 and xylulokinase Xks1, ketoacid decarboxylase Aro10 and alcohol
dehydrogenase Adh2.




Genes involved in isobutanol production (ILV2, ILV3, ILV5, ARO10, and ADH2)
overexpressed in an ald6Δbat1Δ strain (to eliminate competing pathways)
expressing LEU3Δ601 (to activate transcription of endogenous genes in the
valine and leucine biosynthetic pathways)
376.9 mg /L Transcriptional activation
(2014)
[42]
Closed tube cultures with 100 g/L of glucose as substrate
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MLS1 (malate synthase).
Si et al. [43] reported the discovery, characterization
and engineering of an endogenous 1-butanol pathway in
S. cerevisiae, dependent on the catabolism of threonine,
in a similar way to fusel alcohol production by the Ehrlich
pathway. Specifically, the leucine biosynthesis pathway
was engaged in the conversion of key 2-keto acid interme-
diates. Upon introduction of a single gene deletion adh1Δ
(causing deficiency of alcohol dehydrogenase), overexpres-
sion of the Ehrlich pathway enzymes and eradication of
the competing routes, the highest reported 1-butanol titer
by S. cerevisiae was achieved (242.8 mg/L from glucose as
substrate).
Matsuda et al. [39] improved isobutanol yield by S.
cerevisiae strains lacking genes of the pyruvate dehydrogen-
ase complex such as LPD1, to reduce competition between
the pyruvate supply for isobutanol biosynthesis and
acetyl-CoA biosynthesis in mitochondria, together with over-
expression of enzymes responsible for transhydrogenase-like
shunts, converting NADH to NADPH, such as pyruvate
carboxylase, malate dehydrogenase, and malic enzyme,
to resolve cofactor imbalance.
Avalos et al. [40] showed that a greater increase in iso-
butanol synthesis was obtained by compartmentalization
of the Ehrlich pathway into mitochondria (about 260%)
than by overexpression of the same pathway in thecytoplasm (about 10%), in comparison with a strain
overproducing the enzymes that catalyze the first three
steps of the anabolic route. The expected benefits of
mitochondrial compartmentalization are diverse. First, a
local increase in enzyme concentration; second, improved
availability of intermediates, avoiding the necessity
for exporting them outside mitochondria; and third,
it reduces the consumption of intermediates by competing
routes.
Brat and Boles [41] described the construction of a
recombinant S. cerevisiae strain able to produce isobutanol
directly from D-xylose. Simultaneous over-expression
of a cytosolic route of valine biosynthesis and of the
three enzymes xylose isomerase from Clostridium
phytofermentans, transaldolase and xylulokinase allowed
the complementation of the valine auxotrophy of ilv2,3,5
triple deletion mutants and growth on D-xylose as the sole
carbon source. The additional over-expression of ARO10
(ketoacid decarboxilase) and ADH2 (alcohol dehydrogenase)
conferred the cells the ability to directly ferment D-xylose
to isobutanol. This is important because D-xylose can repre-
sent over 30% of plant biomass and in this way the economy
of lignocelulosic hydrolysates fermentation processes
is improved [44].
Park et al. [42] engineered a leucine auxotrophic strain
for the production of isobutanol and 3-methyl-1-butanol
from the catabolism of valine and leucine. The authors
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ase and BAT1 of valine synthesis), and increased transcrip-
tion of endogenous genes in the biosynthetic routes of
these aminoacids, by expressing a constitutively active form
of the Leu3 transcriptional activator.
Also, genome-scale and proteomic analysis, and physio-
logical adaptations, have been performed to improve
butanol and stress tolerance by yeast [45-47].
An overview of the above cited academic papers
describing engineered yeast strains to produce isobutanol
(Table 2), comparing the yields and titers obtained with
such strains, points out to the strain developed by
Matsuda et al. [39] as the highest producer showing a titer
of 1620 mg/L and a yield of 16 mg/g glucose after 24 hours
microaerobic batch fermentation in 100 g/L glucose.
Although this comparison is difficult to perform since
operation time, media and conditions of culture are differ-
ent in each case, there is a higher difference with other
strains in titer (more than double) than in yield since, for
example, Brat et al. [36] report a yield of 14.2 mg/g glu-
cose although with a titer of 630 mg/L from aerobic batch
cultures in 40 g/L glucose. During the preparation of this
review, Generoso et al. [48] reported a comparison among
representative academic yeast strains engineered to
produce butanol isomers (1-, 2- and iso-butanol) that
supports the same here exposed conclusion.
Cheese whey as substrate for butanol production
The remaining liquid after extraction of milk casein
during cheese manufacturing, cheese whey, is relevant
in the dairy industry due to its nutritional composition,
since it retains about 55% of milk nutrients, and is used as
additive in food industries. But, the amount produced,
about 90-95% of the milk volume, generates disposal
problems, which requires viable solutions [49]. Over
160 million tonnes per year are estimated to be produced
in the world, approximately 9-fold the total cheese
production, and the tendency is to increase 1-2%
annually [9]. The biochemical oxygen demand (BOD)
and the chemical oxygen demand (COD) of cheese
whey are 35,000 ppm and a 68,000 ppm respectively
[50]. Only a half of total world cheese whey production
is transformed into various food products [51] and
therefore other uses are necessary to cope out with
the problem.
Whey valorisation is generally initiated by diafiltration
or ultrafiltration to recover whey protein concentrates
(WPC), which have many applications in the food industry
[9,52]. During these processes large volumes of a lactose-
rich stream are also generated. Indeed, lactose, being 70%
of total whey solids, contributes largely to the whey
polluting load [9]. The utilization of lactose present
in whey or permeates is possible through fermentation to
ethanol or butanol [9,51].Lactose metabolism in Clostridium
Several strains of Clostridium acetobutylicum and
Clostridium beijerinckii have been used to produce
butanol by fermentation of whey. However, most of
these studies (88.88% of the works analyzed in this
review) were focused on strains of C. acetobutylicum.
Although relatively little is currently known about the
bioconversion of lactose into butanol, several works
about molecular characterization of lactose transport
and metabolism in C. acetobutylicum ATCC 824
strain (the C. acetobutylicum most employed strain to
ferment the whey, 50% of the studies reported here
used this strain) have been published recently [53,54]. In
this strain, lactose is taken up via the phosphoenol-pyruvate
(PEP)-dependent phosphotransferase system (PTS), which
catalyzes the concomitant uptake and phosphorylation and
deposits the resulting phosphorylated derivative, lactose
6-phosphate, in the cytoplasm. Lactose 6-phosphate is
hydrolyzed to glucose and galactose-6-phosphate by a
phospho-β-galactosidase (Figure 2). Glucose may be
phosphorylated and metabolized to pyruvate via the nor-
mal glycolytic pathway and the galactose-6-phosphate is
generally metabolized to triose phosphates by the tagatose-
6-phosphate pathway [53]. Both PTS and phospho-β-
galactosidase are only induced during growth in lactose,
but are absent in glucose-grown cells. Moreover, this strain
exhibited a classical diauxic growth, in glucose and lactose
medium the lac operon is not expressed until glucose is
consumed. Therefore, lactose transport and metabolism in
this strain seemed to be under the control of a catabolite
responsive element characteristic of low-GC gram-positive
bacteria [53].
Other C. acetobutylicum strains, different from C.
acetobutylicum ATCC 824, such as C. acetobutylicum
P262 (the second C. acetobutylicum most employed strain
to ferment the whey, 43.75% of the studies reported here
used this strain), NCIB 2951, NRRL 594, NRRL 598 and
NRRL 2490, were shown to contain β-galactosidase
besides of phospho-β-galactosidase activities when
grown in lactose medium [55], and a β-galactosidase
gene has been cloned from strain NCIB 2951 [56].
These Clostridia probably possess a non-PTS medi-
ated transport mechanism and lactose is transported
through the cell membrane by a lactose permease
(Figure 2), together with PTS uptake [57]. The galactose re-
leased from the hydrolysis of lactose by the β-galactosidase
is metabolized by the Leloir pathway [54,57]. Interestingly,
during the fermentation of whey permeate by these strains,
the induction of phospho-β-galactosidase was associated
with the acidogenic phase, whereas the β-galactosidase was
induced in the solvent production phase [55].
Recently, genomic information on C. beijerinckii NCIMB
8052, the other main species used in the fermentation of
whey (11.11% of the works analyzed in this review), has
A B
Figure 2 Schematic representation of the different lactose transport and utilization by Clostridium species. A) Phosphoenol-pyruvate
(PEP)-dependent phosphotransferase system (PTS) pathway and B) Lactose permease pathway.
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PTS genes apparently involved in the metabolism of com-
plex carbohydrates, including multiple genes whose protein
products are putatively involved in lactose transport and
metabolism [58]. Therefore, it has been proposed that
lactose metabolism in C. beijerinckii NCIMB 8052 could
be similar to C. acetobutylicum ATCC 824 [59].
All these studies about the genetics and physiology of
lactose uptake and metabolism in Clostridium species
could have theoretical and practical importance to improve
the butanol production from milk whey based on manipu-
lation of these strains and the optimizations of fermentation
conditions.
Lactose utilization by Saccharomyces cerevisae
Although S. cerevisiae is usually the first choice for
industrial processes, it is unable to metabolizee lactose.
Nevertheless, S. cerevisiae can uptake galactose by a
permease coded by the GAL2 gene. Once, inside the
cell, galactose can be further metabolized by the
Leloir pathway. Thus, the first attempts to ferment cheese
whey by S. cerevisiae were based on the pre-hydrolysis of
lactose with β-galactosidase [60] or the use of a biocatalyst
consisting of yeast co-immobilized with β-galactosidase
[61,62], but these processes have limited applicability
due to the diauxic growth showed by S. cerevisiae in glucose
and galactose media. To circumvent this problem, 2-deoxy-
glucose was used as a selection agent to isolate catabolite
repression-resistant mutants of S. cerevisiae [63], which
were able of using glucose and galactose simultaneously.
Genetic engineering techniques allowed the heterologous
expression in S. cerevisiae of the β-galactosidase and lactose
permease genes from Kluyveromyces lactis, performing anintra-cellular hydrolysis of the lactose. Earlier developed
recombinant strains were genetically unstable and grew
slowly in lactose [64]. Both characteristics have been
improved in the later developed strains [65-67].
Other approximation to create lactose-consuming S.
cerevisiae (Lac+) strains consisted in the production by
protoplast fusion of hybrids strains of S. cerevisiae and
Kluyveromyces spp. [68]. The construction of recombinant S.
cerevisiae strains secreting the extracellular β-galactosidase
from Aspergillus niger to the medium [69-71] or S. cerevisiae
expressing and secreting K. lactis β-galactosidase [72,73]
were also reported. In addition, approximations based
on the release of intracellular heterologous β-galactosidase
(e.g. from Escherichia coli or K. lactis) by other means dif-
ferent of secretion have been studied [74,75], also including
the use of S. cerevisiae osmotic-remedial thermosensitive
autolytic mutants [76,77] and cell permeabilization with
toluene or ethanol [78].
However, in spite of the interesting work done, most of
these studies were focused on the fermentation of cheese
whey to ethanol. None of the strategies employed or the
recombinant S. cerevisae strains generated have been used
hitherto to test the butanol production from cheese whey.
Production of butanol by the fermentation of cheese
whey by Clostridium
The relatively low sugar content in whey (lactose
40–50 g/L) is generally a disadvantage for its use in
fermentation processes and requires prior concentration.
However this value is near to optimal for the acetone-
butanol-ethanol (ABE) fermentation, in which product
inhibition limits the amount of sugar consumed. This,
altogether with the ability of C. acetobutylicum to ferment
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tractive alternative substrate for the ABE fermentation. Sev-
eral authors have outlined the value of cheese-whey for
butanol production using various Clostridium species and
whey types for solvent production in conventional batch
fermentation using free cells, and also in continuous fer-
mentation. Although most of the reports were published
during the 1980’s and 1990’s, the butanol production from
cheese-whey is gaining increasing interest during the last
ten years. A brief summary of that is following reported.
Batch production of butanol from whey permeate
Maddox [79] fermented sulphuric acid whey filtrate
using C. acetobutylicum NCIB 2951. The whey filtrate
contained 53 g/L lactose and, after being supplemented
with 5 g/L yeast extract, was adjusted to pH 6.5 and
sterilized. A butanol concentration of 15 g/L was
obtained after 5 days incubation at 30°C. The ratio of
Acetone:Butanol:Ethanol solvents obtained was 1:10:1. If
the yeast extract was not added, only 13 g/L butanol was
obtained after 7 days incubation.
The effect of whey sterilization by autoclaving prior to
batch fermentation using C. acetobutylicum ATCC 824
and the effect of agitation were shown to be important
variables with respect to the solvent ratio produced and
the yield obtained [80]. Generally, agitation was detri-
mental to solvent production with unsterilized and ster-
ilized whey. Moreover, the correlation between lactose
utilization rate and solvent yield was negative [81]. Thus,
in order to favor solventogenesis against acidogenesis, it
is necessary to select conditions such as low culture pH
values or high initial lactose concentrations.
The influence of variations in inoculum pretreatment,
medium composition, pH and fermentation temperature
on butanol fermentation using whey ultrafiltrate with C.
beyerinckii LMD 27.6 were also investigated [82]. A de-
crease in the temperature from 37°C to 30°C greatly
raised the concentration of butanol produced and the
total amount of lactose fermented from whey ultrafil-
trate. Variations of inoculum pretreatment, yeast extract
concentration and pH had no effects on butanol produc-
tion at 37°C. The overall product yields [(kg butanol + kg
isopropanol)/(kg carbohydrated utilized)] were compar-
able between whey ultrafiltrate and glucose medium. But
the batch reactor mean productivity (kg/L.h), including
the lag phase, lowered 2–3 folds whether comparing per-
meate (lactose) with glucose. The lag phase was longer
and substrate conversion rate slower for the permeate
fermentations.
Mixtures of glucose and galactose, present in hydro-
lyzed whey, were also tested in fermentation processes
[82]. Although a preference for glucose was observed,
glucose/galactose mixtures could be used for butanol
production.One interesting observation in the use of whey as the
substrate for fermentation is the unusually high ratio bu-
tanol/acetone. Bahl et al. [83] reported that the fermen-
tation of whey using various C. acetobutylicum strains
yielded a butanol:acetone ratio of approximately 100:1.
This ratio decreased to 2:1 when synthetic media with
only glucose as carbon source was used. The difference
in the solvent ratios obtained on these two media, was
attributed to the more favourable growth conditions in
the whey medium; in particular, the presence of lactic
acid and an intrinsically optimum concentration of iron
supply that is growth limiting and favors butanol
production.
In spite of the work done, in general, whey (or whey
permeate) has proved to be a relatively poor substrate
when overall reactor productivity in batch fermentation
is considered, if compared with starch and molasses sub-
strates [84]. This and the incomplete utilization of lac-
tose, are the two major problems of using whey as a
substrate. Since the concentrations of total solvents pro-
duced are lower than those produced on conventional
substrates, product inhibition does not appear to play a
main role in the poor production of acetone and butanol
from whey. Most solventogenic strains can tolerate a
maximum level of total ABE of 20 g/L [85] and 32.6 g/L
[86] for the genetically manipulated hiper-solvent produ-
cing strain, C. beijerinckii BA101. At these solvent con-
centrations, the fermentation is completely inhibited.
The maximum total ABE reported up to now by strains
fermenting whey was 17 g/L [79].
Besides product inhibition, ABE fermentation is af-
fected by other factors such as inhibition by substrate or
salt concentration. It is also diminished by dead cells in-
crease, nutrient deficiency, low water activity, accumula-
tion of polysaccharides and other macromolecules, or
undesired O2 losses in connecting tubes that are pro-
duced during the feeding of nutrients into the fermentor
[5,87,88]. Remarkably, high concentrations (about 200 g/
L) of whey permeate (lactose) did not cause substrate in-
hibitory effect [87], opposite to glucose that showed in-
hibitory effects at concentrations greater than 161 g/L
[88].
More recently, Foda et al. [89] investigated the suit-
ability of lactose containing substrates in batch fermen-
tation using C. acetobutylicum DSM 792 and C.
acetobutylicum AS 1.224. In aerobic conditions, using
lactose medium, C. acetobutylicum DSM 792 was better
for solvents production than AS 1.224 in laboratory con-
ditions. In bioreactor batch experiments, using lactose
and cheese whey media, these authors demonstrated that
cheese whey is an excellent substrate for biobutanol pro-
duction with clear advantages respect to lactose medium
(1.5 g/L of butanol production in cheese whey media
versus 0.71 g/L of butanol in lactose medium).
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milk dust powder, for ABE fermentation was evaluated
recently [59]. Milk dust is a blend of different milk
powders left over after industrial milk packaging with high
lactose content. Batch fermentation of milk dust powder
by C. acetobutylicum and C. beijerinckii produced 7.3 and
5.8 g/L of butanol respectively and, similar to previous re-
ports for whey [83], both species favors butanol produc-
tion over acetone compared to fermentation with glucose.
Continuous production of butanol from whey permeate
Butanol was produced continuously from whey permeate
using cells of C. beijerinckii LMD 27.6, immobilized in
calcium alginate beads [90]. The best production parame-
ters in these conditions were 30°C during fermentation and
a dilution rate of 0.1 h−1 or less during the start-up phase.
In these conditions the reactor productivities were sixteen
times higher than those obtained in batch cultures using
free C. beijerinckii cells grown on whey media.
Production of solvents from whey permeate was also
achieved using adsorbed cells of C. acetobutylicum onto
bonechar in a packed bed reactor (PBR) in continuous
that was operated for 61 days maintaining stable conditions
[91]. The maximum solvent productivity (4.1 g/L.h) was
reached at a dilution rate of 1.0 h−1; this value represents a
yield of 0.23 g solvent/g lactose utilized. Solventogenesis
was favoured at high concentrations of lactose in the
whey permeate, while low concentrations stimulated
acidogenesis.
Ennis and Maddox [92] investigated the ABE continu-
ous fermentation of whey permeate using the strain C.
acetobutylicum P262A. Cells were recycled by using a
dispositive able of being backflushed and consisting on a
tubular cross-flow microfiltration (CFM) membrane plant.
Cyclic solventogenic and acidogenic behaviour was
observed along the continuous fermentation. However,
finally it changed to a predominantly acidogenic state,
with only short periods of steady-state solvent production.
Solventogenic or acidogenic behaviour is correlated with
specific morphological cell forms; thus vegetative cells
produce acid, while clostridial cells produce solvent. It has
been suggested that is necessary to maintain a balance
among the various morphological cell forms (vegetative,
clostridial and spores) in order to maintain steady-state
solvent production during a long time. In this report [92]
the loss of this necessary balance was attributed to
morphological changes of C. acetobutylicum P262A grown
on whey permeate.
Also stable biofilms of C. acetobutylicum were prepared
for continuous fermentation processes using lactose and
yeast extract as substrates; a packed bed reactor, con-
taining hydrophobic plastic carriers was prepared and
best results of fermentation were obtained by increasing
dilution rate and pH [93].Yeast extract is a necessary supplement when using
whey permeate as a substrate for solvent production,
presumably as a nutrient source; effectively Maddox
demonstrated that batch fermentation without this
supplement performed less well [79]. Raganati et al.
[94] investigated the feasibility of butanol production
by C. acetobutylicum DSM 792 by continuous conversion
of un-supplemented deproteinized cheese whey. The
experiment was performed for more than 3 months in a
PBR using Tygon rings as biofilm carriers. The lowest D
(dilution rate) investigated gave best performance for the
butanol/solvent production. These results were consistent
with those reported by Qureshi and Maddox [91], but
Raganati [94] obtained better performances when PBRs
were operated in absence of yeast extract and with 28 g/L
lactose in the feeding (under close operating conditions).
An assessment of the growth kinetics [11] and of both
the growth and the metabolism [95] of acidogenic cells
of C. acetobutylicum DSM 792 were reported. Both tests
were carried out under controlled conditions in a
continuous stirred tank reactor using a synthetic medium
with lactose as carbon source. The proposed models
predict the microorganism growth rate [11] or estimate
the mass fractional yield [95] under a broad range of
operating conditions, including those necessary for
solvents production.
Fed-batch and batch culture coupled with an in situ
recovery process
The economic feasibility of classical fed-batch or continuous
cultivation is hampered by solvent toxicity and the biphasic
performance of acetone-butanol fermentation, respectively.
To avoid these problems, in situ recovery processes have
been coupled with fed-batch and batch cultures.
Employing silicone membrane and oleyl alcohol as the
perstraction solvent, the integrated ABE fermentation by
perstraction was investigated using whey permeate and
lactose as substrates [96]. Subsequently, 57.8 g of ABE were
produced with ABE productivity of 0.24 g/L.h. The mem-
brane allowed butanol diffusion into the extractant, but dif-
fusion of acetone and acids were limited, which resulted in
a higher ABE yield of 0.37 g/g due to acid re-assimilation.
A batch fermentation process coupled with simultaneous
product removal by gas stripping has been assayed
[87]. In this way, a semi-synthetic medium containing
lactose up to 200 g/L has been completely fermented
by C. acetobutylicum P262 to 70 g/L of ABE.
An integrated system coupled with liquid-liquid
extraction significantly enhanced lactose utilization
from whey permeate, using C. acetobutylicum P262
immobilized cells in a fluidized bed bioreactor, with
feeble reduction in productivity [97].
Later, Qureshi and Maddox [98] coupled ABE production
from whey permeate medium supplemented with lactose,
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removal by perstraction. 136.6 g/L of ABE were produced
from 313.3 g/L lactose with a yield of 0.44 g/g and product-
ivity of 0.21 g/L.h. Using ABE removal by perstraction, the
ratio of acids to solvents was significantly lower than in the
control batch process, thus indicating the conversion of
acids into solvents.
The butanol productivity (g/L h) and the butanol con-
centration (g/L) were chosen to compare the works ana-
lyzed in this section (Figure 3). The references [83] and
[95] were not included in the Figure 3 because data do
not allow comparable calculations. The highest butanol
productivity (2.7 g/L h) was reached with C. acetobutylicum
P262 immobilized by adsorption onto bonechar growing in
whey permeate supplemented with yeast extract in a
continuous PBR [91], followed (2.66 g/L h) by C.
acetobutylicum DSM 792 growing in un-supplemented
deproteinized cheese whey in a continuous PBR [94]. The
highest butanol concentration (15 g/L) was obtained after
5 days incubation by C. acetobutylicum NCIB 2951 growing
in acid whey filtrate supplemented with yeast extract in
batch mode [79] followed (14.64 g/L) by C. acetobutylicum
DSM 792 growing in synthetic medium supplemented with
lactose in continuous stirred tank reactor [11]. In general,
batch fermentation gave poor productivity and continuous
fermentation processes with C. acetobutylicum DSM 792
strain (corresponds to ATCC 824) gave better performance
both in butanol productivity and butanol concentration.
However, the industrial hurdle rate estimate of 5 g/L h of
butanol productivity [99] is far to achieve. Overall,
the results support the view that further investigation of
whey (permeate) as a substrate for the ABE fermentation
is desirable.
Conclusion and perspectives
The increasing attractive of biobutanol as fuel reveals new
opportunities for the utilization of by-products from the


































Figure 3 Butanol productivity (g/L h) versus Butanol concentration (g
fermentation; Square: Continuous fermentation; Triangle: Fermentation cou
strain; Red: C. acetobutylicum ATCC 824 strain; Yellow: C. acetobutylicum NCproduction has been scarcely explored, although this is a
desirable objective. Several plants producing bioethanol
from whey are operating [9] and the combined production
of bioethanol and biobutanol could improve the economic
interest and also contribute to obtain a more efficient
biofuel. Considering that production of biofuels is a useful
mean to slow down carbon dioxide emissions, this is also
a green-industry with ecological benefits to humankind
and that could contribute to decrease present concerns
over global climate change.
The production of biobutanol from whey is theoretic-
ally possible since solventogenic Clostridia are able to
grow with lactose as carbon source, and direct assays of
this production are here reviewed. Proteins, which are as
well major components of whey composition, could even
be considered as substrates for biobutanol production.
Recently an E. coli strain was engineered to grow on
13 amino acids as the unique carbon source and it
was able to produce 406 mg/L of bio-alcohols (isobutanol,
2-methyl butanol, and 3-methyl butanol) from yeast
extract [100].
The establishment of advanced biofuel production
from whey sources is still a developing field and a long
way remains to be run. Fortunately new tools and strat-
egies are available nowadays to speed the process. Strain
development by engineering microorganisms with the
appropriate pathways and pathway optimization, eliminat-
ing bottlenecks and avoiding toxicity, are now assisted by
the “omics” technology and the systems biology approach.
New strategies might be used to optimize synthetic
combined enzyme activity and the resulting metabolic flux
by the “co-localization” concept. The co-localization of
diverse proteins participating in the pathway can be
achieved in the cell either by enzyme fusion, directed
protein trafficking, or the use of scaffolding proteins.
All these possibilities have been thoroughly reviewed
[101] and could be applied to successful biobutanol
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